A. Mougel

发表

Inhibition of Latent Membrane Protein 1 Impairs the Growth and Tumorigenesis of Latency II Epstein-Barr Virus-Transformed T Cells

O. Melnyk, O. Moralès, E. Adriaenssens, 2012, Journal of Virology.

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

E. Adriaenssens, J. Coll, T. Ouk, 2010, Cellular signalling.

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist

O. Melnyk, H. Drobecq, E. Gherardi, 2022, bioRxiv.

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist

O. Melnyk, H. Drobecq, E. Gherardi, 2022, Life Science Alliance.

Anti-apoptotic Role of Caspase-cleaved GAB1 Adaptor Protein in Hepatocyte Growth Factor/Scatter Factor-MET Receptor Protein Signaling*

Y. De Launoit, J. Vicogne, V. Fafeur, 2012, The Journal of Biological Chemistry.

Estradiol regulates the insulin-like growth factor-I (IGF-I) signalling pathway: a crucial role of phosphatidylinositol 3-kinase (PI 3-kinase) in estrogens requirement for growth of MCF-7 human breast carcinoma cells.

J. Ricort, E. Adriaenssens, A. Mougel, 2006, Biochemical and biophysical research communications.

Human Monocytic Cell Lines Transformed In Vitro by Epstein-Barr Virus Display a Type II Latency and LMP-1-Dependent Proliferation

C. Montpellier, P. Crépieux, E. Adriaenssens, 2002, Journal of Virology.

A novel dominant-negative mutant form of Epstein–Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways

E. Adriaenssens, J. Coll, C. Auriault, 2004, Oncogene.

Correction: A simple and traceless solid phase method simplifies the assembly of large peptides and the access to challenging proteins

O. Melnyk, H. Drobecq, R. Desmet, 2017, Chemical science.

Nerve growth factor is a potential therapeutic target in breast cancer.

H. Hondermarck, V. Nurcombe, E. Adriaenssens, 2008, Cancer research.

Induction of Therapeutic Antibodies by Vaccination against External Loops of Tumor-Associated Viral Latent Membrane Protein

C. Verwaerde, A. Mougel, C. Delbende, 2009, Journal of Virology.

Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression

E. Adriaenssens, X. Le Bourhis, J. Vicogne, 2022, International journal of molecular sciences.

Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors

M. Copin, O. Melnyk, J. Bonte, 2018, Oncotarget.

Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-κB and JNK Signaling Pathways

G. Bornkamm, E. Adriaenssens, J. Coll, 2006, Journal of Virology.

A Central Cysteine Residue Is Essential for the Thermal Stability and Function of SUMO-1 Protein and SUMO-1 Peptide-Protein Conjugates.

O. Melnyk, H. Drobecq, Jean-Michel Saliou, 2016, Bioconjugate chemistry.

Breast Cancer Nerve Growth Factor Is a Potential Therapeutic Target in

H. Hondermarck, V. Nurcombe, E. Adriaenssens, 2008 .

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist

O. Melnyk, H. Drobecq, E. Gherardi, 2020, bioRxiv.

LMP1-Induced Cell Death May Contribute to the Emergency of Its Oncogenic Property

E. Adriaenssens, J. Coll, X. Le Bourhis, 2013, PloS one.

A novel dominant-negative mutant form of Epstein–Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways

E. Adriaenssens, J. Coll, C. Auriault, 2004, Oncogene.

Transformation of Receptor Tyrosine Kinases into Glutamate Receptors and Photoreceptors

D. Trauner, C. Dissous, K. Cailliau, 2020, Angewandte Chemie.

Transformation of Receptor Tyrosine Kinases into Glutamate Receptors and Photoreceptors.

D. Trauner, C. Dissous, K. Cailliau, 2019, Angewandte Chemie.

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

E. Adriaenssens, J. Coll, T. Ouk, 2010, Cellular signalling.

Inhibition of Latent Membrane Protein 1 Impairs the Growth and Tumorigenesis of Latency II Epstein-Barr Virus-Transformed T Cells

O. Melnyk, O. Moralès, E. Adriaenssens, 2012, Journal of Virology.

A minimal hepatocyte growth factor mimic acting as a powerful agonist of the MET receptor tyrosine kinase for regeneration of epithelial tissues and organs. Short Title: Kringle 1 dimer as a minimal MET agonist. Authors

H. Drobecq, E. Adriaenssens, J. Vicogne, 2022 .

Optimized protocols for RNA interference in Macrostomum lignano

J. Vicogne, A. Mougel, Stijn Mouton, 2023, bioRxiv.

Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist

O. Melnyk, H. Drobecq, S. Cianférani, 2015, Chemical science.